Investigational tolebrutinib slowed disability progression in people with non-relapsing secondary progressive multiple ...

The following is a summary of “Limited added value of systematic spinal cord MRI vs brain MRI alone to classify patients with ...

Can your brain start consuming itself during a marathon? New research says yes- but don’t panic, your brain bounces back in ...

Data from an open-label extension of VISIONARY-MS support an association between gold nanocrystals and neuronal repair and remyelination in patients with stable multiple sclerosis and visual deficits, ...

Treatment with CNM-Au8 led to clinical improvements in relapsing-remitting MS patients that linked to signs of nerve cell ...

Marathon runners experience reversible changes in their brain myelin. These findings indicate that myelin (a substance that surrounds the neurons) exhibits behavior that was previously unknown, and ...

Tolebrutinib, a brain-penetrant BTK inhibitor, may fill a significant unmet need by delaying disability progression in patients with non-relapsing secondary progressive multiple sclerosis.

Frexalimab was well tolerated and maintained disease control over two years in adults with relapsing MS in an open-label ...

Long-term data from the VISIONARY-MS Phase 2 trial links improved brain imaging and visual evoked potentials to remyelination and neuronal repair in MS patients treated with CNM-Au8.

In people with schizophrenia, NfL levels appeared to increase more quickly with age, compared with the rate of increase in ...

And, in an interview on SiriusXM's This Life of Mine with James Corden last year, Applegate discussed the weird symptoms ...

THE London Marathon is waiting a Chester woman who lives with multiple sclerosis as she raises money for a charity that support people with ...